Yahoo Web Search

  1. Retrophin (RTRX) Q2 2019 Earnings Call Transcript

    Motley Fool via Yahoo FinanceAug 07 12:25 PM

    Today's call will be led by our chief executive officer, Dr. Eric Dube. Dr. Bill Rote, our senior vice president of research and development, will join us for the Q&A session.

  2. Rigel Pharmaceuticals Inc (RIGL) Q2 2019 Earnings Call Transcript

    Motley Fool via Yahoo FinanceAug 07 1:24 AM

    It is now my pleasure to introduce our first speaker, Dolly Vance, who is Rigel's Executive Vice President, Corporate Affairs and General Counsel. As a reminder, during today's call, we may ...

  3. Abeona Therapeutics Inc (ABEO) Q2 2019 Earnings Call Transcript

    Motley Fool via Yahoo FinanceAug 12 22:23 PM

    For opening remarks and introductions, I'll turn the call over to Sofia Warner, Senior Director, Investor Relations. Today's call will be led by Joao Siffert, our Chief Executive Officer.

  4. Halozyme Therapeutics Inc (HALO) Q2 2019 Earnings Call Transcript

    Motley Fool via Yahoo FinanceAug 08 14:58 PM

    I would now like to turn the conference over to Al Kildani, Vice President of Investor Relations and Corporate Communications for Halozyme Therapeutics. Good afternoon, everyone and thank you for joining us today.

  5. Eloxx Pharmaceuticals, Inc. (ELOX) Q2 2019 Earnings Call Transcript

    Motley Fool via Yahoo FinanceAug 08 16:51 PM

    At this time I'd like to turn the call over to Barbara Ryan, Eloxx Investor Relations Officer. Thank you, operator, and welcome and thank you for joining us this morning for a review of Eloxx ...

  6. This September, during a two-day international conference convened by the Austen Riggs Center, leading experts in the fields of mental health treatment, research, advocacy, and ...

  7. Edited Transcript of RTRX earnings conference call or presentation 6-Aug-19 8:30pm GMT

    Thomson Reuters StreetEvents via Yahoo FinanceAug 14 8:25 AM

    THIOLA's performance remained steady. Notably, we started off the summer with the approval of THIOLA EC, a great step towards -- forward in the cystinuria community that will provide ...

  8. Edited Transcript of CYCC earnings conference call or presentation 13-Aug-19 8:30pm GMT

    Thomson Reuters StreetEvents via Yahoo FinanceAug 14 9:59 AM

    In 2 clinical studies, we are treating patients with relapsed refractory CLL and separately relapsed refractory AML or MDS with a combination of CYC065 and venetoclax. This combination strategy ...

  9. Edited Transcript of ABEO earnings conference call or presentation 12-Aug-19 2:00pm GMT

    Thomson Reuters StreetEvents via Yahoo FinanceAug 15 21:10 PM

    The VITAL Phase III study will be a multi-center, randomized clinical trial assessing EB-101 for treatment of approximately 35 wound sites across 10 to 15 RDEB patients. The primary ...

  10. Edited Transcript of ABMD earnings conference call or presentation 1-Aug-19 12:00pm GMT

    Thomson Reuters StreetEvents via Yahoo FinanceAug 07 13:42 PM

    I would like to share a recent patient story. Last January, [Soma...received CPR and was shocked several times on the way to Memorial Hermann-Texas Medical Center. At this point, Dr.

  1. Ads
    related to Community Treatment Center, Inc